Exact Mass: 676.2875
Exact Mass Matches: 676.2875
Found 160 metabolites which its exact mass value is equals to given mass value 676.2875
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5',8,8'-Trihydroxy-3',3',4',4',5',7',7'-heptamethoxy-5,5'-biflavan
5,8,8-Trihydroxy-3,3,4,4,5,7,7-heptamethoxy-5,5-biflavan is found in fruits. 5,8,8-Trihydroxy-3,3,4,4,5,7,7-heptamethoxy-5,5-biflavan is a constituent of the roots of Muntingia calabura (Jamaica cherry). Constituent of the roots of Muntingia calabura (Jamaica cherry). 5,8,8-Trihydroxy-3,3,4,4,5,7,7-heptamethoxy-5,5-biflavan is found in fruits.
Taccalonolide AJ
Nulev
Hyoscyamine Sulfate is the sulfate salt of a belladonna alkaloid derivative and the levorotatory form of racemic atropine isolated from the plants Hyoscyamus niger or Atropa belladonna, which exhibits anticholinergic activity. Hyoscyamine functions as a non-selective, competitive antagonist of muscarinic receptors, thereby inhibiting the parasympathetic activities of acetylcholine on the salivary, bronchial, and sweat glands, as well as the eye, heart, bladder, and gastrointestinal tract. These inhibitory effects cause a decrease in saliva, bronchial mucus, gastric juices, and sweat. Furthermore, its inhibitory action on smooth muscle prevents bladder contraction and decreases gastrointestinal motility. The 3(S)-endo isomer of atropine.
Chlorahololide D
3,8,14,17,20-Pentaacetyl-7-(2-methylbutanoyl)-synadenol
tricalysioside H 19-O-beta-D-glucopyranosyl ester|tricalysioside Z
1beta,2beta,6alpha,8beta-tetraacetoxy-9beta-benzoyloxy-12-isobutanoyloxy-4alpha-hydroxy-beta-dihydroagarofuran
(16R,17S)-17,18-epoxy-10,17-bis-beta-D-glucopyranosyloxy-16-vinyl-(3beta,15betaH)-19-nor-coryn-18(20)-en-21-one|10,17beta-bis-beta-D-glucopyranosyloxy-16alpha-vinyl-(3beta,15beta)-18-oxa-yohimb-19-en-21-one|10-beta-D-glucopyranosyloxy-vincosamide
2alpha,7alpha-diacetoxy-1alpha,3alpha-dibenzoyloxy-8beta-hydroxyisopimarane-11,14-dione|orthoarisin G
3alpha,7alpha-diacetoxy-2alpha,11alpha-dibenzoyloxy-1alpha,8beta-dihydroxyisopimar-15-en-14-one|orthoarisin A
1alpha,2alpha-diacetoxy-8beta-isobutanoyloxy-9alpha-benzoyloxy-13-(alpha-methyl)butanoyloxy-4beta,6beta-dihydroxy-beta-dihydroagarofuran|1beta,2beta-diacetoxy-4alpha,6alpha-dihydroxy-8alpha-isobutanoyloxy-9beta-benzoyloxy-15-(alpha-methyl)butanoyloxy-beta-dihydroagrofuran
(3beta,15beta,16alpha,17beta)-19,20-didehydro-16-ethenyl-17-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-11-hydroxyoxayohimban-21-one|2-beta-D-glucopyranosyl-11-hydroxyvincoside lactam
(1S,5S,5aS,6R,7R,8aS,9aS,10aS,11R,11aR,12S,13R,13aR)-11,12,13-tris(acetyloxy)-5,5a,5b,6,6a,6b,7,8a,9,9a,10a,11,11a,11b,12,13,13a,13b-octadecahydro-1,5,6,7-tetrahydroxy-1,5,5a,11a,13a-pentamethyl-1H-oxireno[6,7]naphtho[1,2:7,8]fluoreno[2,1-b]furan-4,8-dione|taccalonolide W
C31H48O16_alpha-D-Glucopyranoside, 4-O-acetyl-6-O-(2-methyl-1-oxobutyl)-1-O-(3-methyl-1-oxobutyl)-beta-D-fructofuranosyl 2-O-[(2E)-2-methyl-1-oxo-2-buten-1-yl]-, 6-acetate
5',8,8''-Trihydroxy-3',3''',4',4''',5''',7',7''-heptamethoxy-5,5''-biflavan
Camptosar
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors
(6-Methyl-6-azabicyclo[3.1.1]heptan-3-yl)methyl 3-hydroxy-2-phenylpropanoate;sulfuric acid
[(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] 5-methyl-1H-pyrrole-2-carboxylate
(2S)-2-(3-hydroxy-4,5-dimethoxyphenyl)-5-[(2S)-8-hydroxy-7-methoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-chromen-5-yl]-7-methoxy-3,4-dihydro-2H-chromen-8-ol
(8R)-7-[(2-benzoylphenyl)-oxomethyl]-3-[3-[(1-oxo-3,3-diphenylpropyl)amino]phenyl]-1-oxa-2,7-diazaspiro[4.4]non-2-ene-8-carboxamide
(2R,2(1)S)-2(1),2(2)-dicarboxy-8-ethenyl-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-13,17-dipropanoic acid
(2S,2(1)R)-2(1),2(2)-dicarboxy-8-ethenyl-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-13,17-dipropanoic acid
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-(2-thiazolyl)benzamide
(2R,4S,5R,6R)-5-Acetamido-2-[(2R,3R,4R,5S)-5-acetamido-2,4,6-trihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
(2R,4S,5R,6R)-5-Acetamido-2-[(2R,3S,4R,5S)-5-acetamido-2,3,6-trihydroxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
(2R,4S,5R,6R)-5-Acetamido-2-[(2R,3S,4R,5S)-5-acetamido-2,3,6-trihydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
(2S,4S,5R,6R)-5-Acetamido-2-[(2S,3R,4S,5S,6R)-2-[(2R,3R,4R,5S)-5-acetamido-1,2,4,6-tetrahydroxyhexan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
(2S,4S,5R,6R)-5-Acetamido-2-[(3R,4S,5S,6R)-2-[(2S,3R,4S,5R)-2-acetamido-1,4,5,6-tetrahydroxyhexan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
(2S,4S,5R,6R)-5-Acetamido-2-[(2R,3R,4S,5S,6R)-2-[(2S,3R,4S,5R)-2-acetamido-1,4,5,6-tetrahydroxyhexan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
2-(3-hydroxy-4,5-dimethoxyphenyl)-5-[8-hydroxy-7-methoxy-2-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-1-benzopyran-5-yl]-7-methoxy-3,4-dihydro-2H-1-benzopyran-8-ol
(2S),(2S)-8,8-5-trihydroxy-7,7-3,3-4,4-5-heptamethoxy-5,5-biflavan
A biflavonoid obtained by coupling of 8,3-dihydroxy-7,4,5-trimethoxyflavan and 8-hydroxy-7,3,4,5-tetramethoxyflavan resulting in a bond between C-5 positions of the two chromene rings. Isolated from Muntingia calabura, it exhibits antineoplastic activity.
Azilsartan mopivabil
Azilsartan mopivabil is the potent antagonist of angiotensin II receptor[1].
(2r,4r,4as,4bs,5r,6s,7s,8as,10r,10ar)-7,10-bis(acetyloxy)-5-(benzoyloxy)-2-ethenyl-6,10a-dihydroxy-2,4b,8,8-tetramethyl-1-oxo-octahydro-3h-phenanthren-4-yl benzoate
1,3-ditrimethylsilyl (1r,2r,3s,4s)-2,4-bis({3-methoxy-4-[(trimethylsilyl)oxy]phenyl})cyclobutane-1,3-dicarboxylate
18-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-19-ethenyl-6-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15-pentaen-14-one
(2r,3r,3as,4r,7r,8s,12s,13ar)-4,7-bis(acetyloxy)-3-(benzoyloxy)-2,13a-dihydroxy-2,9,9,12-tetramethyl-5-methylidene-13-oxo-1h,3h,3ah,4h,6h,7h,8h,12h-cyclopenta[12]annulen-8-yl benzoate
4,7,8,15,16-pentakis(acetyloxy)-5,9,12,12-tetramethyl-17-oxapentacyclo[7.6.2.0¹,¹⁰.0³,⁷.0¹¹,¹³]heptadecan-2-yl 2-methylbut-2-enoate
methyl (1s,4s,5r,6s,7s,8r,11r,12r,14s,15s)-12-(acetyloxy)-4,7-dihydroxy-6-[(1s,2s,6s,8s,9r,11s)-2-hydroxy-11-methyl-5,7,10-trioxatetracyclo[6.3.1.0²,⁶.0⁹,¹¹]dodec-3-en-9-yl]-6,11-dimethyl-14-{[(2e)-2-methylbut-2-enoyl]oxy}-3,9-dioxatetracyclo[6.6.1.0¹,⁵.0¹¹,¹⁵]pentadecane-4-carboxylate
4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-({2,3,6-trihydroxy-5-[(1-hydroxyethylidene)amino]-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexyl}oxy)-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid
3,9-bis(acetyloxy)-4-(benzoyloxy)-7-ethenyl-5,8a-dihydroxy-1,1,4a,7-tetramethyl-8-oxo-octahydro-2h-phenanthren-2-yl benzoate
(2r,4s,5r,6r)-4-hydroxy-5-[(1-hydroxyethylidene)amino]-2-{[(2r,3s,4s,5s)-2,3,6-trihydroxy-5-[(1-hydroxyethylidene)amino]-4-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexyl]oxy}-6-[(1r,2r)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
7-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-4',5,5',7',10-pentahydroxy-2,2,2'-trimethyl-1,3-dihydro-[1,1'-bianthracene]-4,9',10'-trione
(2s,3s,4r,4as,4bs,5r,7r,8ar,9r)-3,9-bis(acetyloxy)-4-(benzoyloxy)-7-ethenyl-5,8a-dihydroxy-1,1,4a,7-tetramethyl-8-oxo-octahydro-2h-phenanthren-2-yl benzoate
methyl (1s,4r,5r,6s,7s,8r,11r,12r,14s,15s)-12-(acetyloxy)-4,7-dihydroxy-6-[(1s,2s,6s,8s,9r,11s)-2-hydroxy-11-methyl-5,7,10-trioxatetracyclo[6.3.1.0²,⁶.0⁹,¹¹]dodec-3-en-9-yl]-6,11-dimethyl-14-{[(2e)-2-methylbut-2-enoyl]oxy}-3,9-dioxatetracyclo[6.6.1.0¹,⁵.0¹¹,¹⁵]pentadecane-4-carboxylate
(1r,3r,4s,5r,7s,8s,9r,10e,12s,13s,14s)-4-(acetyloxy)-3,6,6,10,14-pentamethyl-8,13-bis({[(2e)-2-methylbut-2-enoyl]oxy})-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-9-yl benzoate
19-hydroxy-3'-methoxyaglaine c
{"Ingredient_id": "HBIN002194","Ingredient_name": "19-hydroxy-3'-methoxyaglaine c","Alias": "NA","Ingredient_formula": "C37H44N2O10","Ingredient_Smile": "CCC(C)(C(=O)NC1CCCN1C(=O)C2C(C3(C(C2(C4=C(C=C(C=C4O3)OC)OC)O)O)C5=CC(=C(C=C5)OC)OC)C6=CC=CC=C6)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10378","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1α,2α-diacetoxy-8β-isobutanoyloxy-9α-benzoyl-oxy-13-(α-methyl)butanoyloxy-4β,6β-dihydroxy-β-dihydroagarofuran
{"Ingredient_id": "HBIN002274","Ingredient_name": "1\u03b1,2\u03b1-diacetoxy-8\u03b2-isobutanoyloxy-9\u03b1-benzoyl-oxy-13-(\u03b1-methyl)butanoyloxy-4\u03b2,6\u03b2-dihydroxy-\u03b2-dihydroagarofuran","Alias": "NA","Ingredient_formula": "C35H48O13","Ingredient_Smile": "CCC(C)C(=O)OCC12C(C(CC(C13C(C(C(C2OC(=O)C4=CC=CC=C4)OC(=O)C(C)C)C(O3)(C)C)O)(C)O)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5311","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-(β-xylosyl)-10-deacetylbaccatin iii
{"Ingredient_id": "HBIN013119","Ingredient_name": "7-(\u03b2-xylosyl)-10-deacetylbaccatin iii","Alias": "NA","Ingredient_formula": "C34H44O14","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22830","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-xylosyl-10-deacetylbaccatin
{"Ingredient_id": "HBIN013496","Ingredient_name": "7-xylosyl-10-deacetylbaccatin","Alias": "NA","Ingredient_formula": "C34H44O14","Ingredient_Smile": "CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)OC6C(C(C(CO6)O)O)O)C)O","Ingredient_weight": "676.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32245","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5315356","DrugBank_id": "NA"}
7-xylosyl-10-deacetylbaccatin iii
{"Ingredient_id": "HBIN013497","Ingredient_name": "7-xylosyl-10-deacetylbaccatin iii","Alias": "NA","Ingredient_formula": "C34H44O14","Ingredient_Smile": "CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)OC6C(C(C(CO6)O)O)O)C)O","Ingredient_weight": "676.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32246","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137704373","DrugBank_id": "NA"}
Azadirachtin D
{"Ingredient_id": "HBIN017425","Ingredient_name": "Azadirachtin D","Alias": "NA","Ingredient_formula": "C34H44O14","Ingredient_Smile": "CC=C(C)C(=O)OC1CC(C2(COC3C2C14COC(C4C(C3O)(C)C56C7CC(C5(O6)C)C8(C=COC8O7)O)(C(=O)OC)O)C)OC(=O)C","Ingredient_weight": "676.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32404","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102063005","DrugBank_id": "NA"}